Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Treasury Shares (2022 - 2025)

Historic Treasury Shares for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $51849.0.

  • bioAffinity Technologies' Treasury Shares fell 9576.94% to $51849.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $51849.0, marking a year-over-year decrease of 9576.94%. This contributed to the annual value of $44107.0 for FY2024, which is 9184.67% down from last year.
  • Latest data reveals that bioAffinity Technologies reported Treasury Shares of $51849.0 as of Q3 2025, which was down 9576.94% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Treasury Shares ranged from a high of $1.6 million in Q1 2025 and a low of $44107.0 during Q4 2024
  • Moreover, its 4-year median value for Treasury Shares was $885218.0 (2024), whereas its average is $772540.0.
  • As far as peak fluctuations go, bioAffinity Technologies' Treasury Shares surged by 37073.53% in 2023, and later plummeted by 9576.94% in 2025.
  • Over the past 4 years, bioAffinity Technologies' Treasury Shares (Quarter) stood at $114920.0 in 2022, then soared by 370.74% to $540969.0 in 2023, then plummeted by 91.85% to $44107.0 in 2024, then increased by 17.55% to $51849.0 in 2025.
  • Its last three reported values are $51849.0 in Q3 2025, $1.6 million for Q2 2025, and $1.6 million during Q1 2025.